Asahi Kasei Offers $1.1B for Swedish Pharma Calliditas Therapeutics 5/28/2024

AstraZeneca, Daiichi Sankyo ADC Misses Endpoint in Phase III NSCLC Study 5/28/2024

NS Pharma’s DMD Candidate Viltespo Fails Confirmatory Phase III Trial 5/28/2024

Novo Nordisk’s Once-Weekly Insulin Loses FDA Adcomm Vote for Type 1 Diabetes 5/28/2024

Novartis Eyes Rare Kidney Disease Approvals on Heels of Two Phase III Wins 5/28/2024

30 Years After Genetic Discovery, Huntington’s Patients Still Waiting 5/28/2024

Despite Progress, ADCs Still Stalled in Non-Small Cell Lung Cancer 5/28/2024

Precision Medicine and Novel Approaches on Cusp of Breaking Through in Psychiatry 5/28/2024

Opinion: How to Make Today’s Clinical Research More Efficient 5/28/2024

Lilly Invests Another $5.3B in Indiana Plant to Boost Tirzepatide Manufacturing 5/24/2024

Novo Nordisk’s Semaglutide Cuts Death Risk in Diabetics with CKD in Phase III Trial 5/24/2024

ASCO24: J&J Reports Four Patient Deaths in Early-Stage Prostate Cancer Trial 5/24/2024

ASCO24: Regeneron’s Bispecific Antibody Falls Flat in Early Study 5/24/2024

Is AstraZeneca’s $80B Revenue Goal By 2030 a Bridge Too Far? 5/24/2024

ASCO24: Nimbus Plots Path for Next-Gen IO Therapies with Strong Early HPK1 Blocker Data 5/24/2024

Zealand Touts Phase I Results for GLP-1, GLP-2 Candidate Despite Modest Weight Loss 5/24/2024

Takeda Joins Hot Molecular Glue Market With $1.2B Deal 5/23/2024

Pfizer Targets Another $1.5B in Cost Cuts By End of 2027 5/23/2024

Tango Stops Early Cancer Trial Over Liver Toxicity, Drops Out of Race Against Roche 5/23/2024

Orna Buys Competing RNA Biotech ReNAgade After Series A Financing 5/23/2024